Mark Houston Hoofnagle
Research Subjects
Mark Houston Hoofnagle has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Gary K. Owens
Robert M. Berne Cardiovascular Research Center (R.A.D., T.R., V.M.M., L.S.S., A.M.C., A.S., S.B., G.K.O.), University of Virginia School of Medicine, Charlottesville
8 shared publications - Sanjay Sinha
Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK
6 shared publications Brian R. Wamhoff
From the Department of Molecular Physiology and Biological Physics (M.H.H., J.A.T., G.K.O.) and the Department of Medicine, Cardiovascular Division (B.R.W.), University of Virginia, Charlottesville
4 shared publicationsGary K. Owens
Cardiovascular Research Center, The University of Virginia
4 shared publicationsChristine Chabasse
Center for Vascular and Inflammatory Diseases and the Department of Surgery, University of Maryland School of Medicine, Baltimore, Md
3 shared publicationsSarbani Ghosh
Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by American Society of Hematology in Blood
Restoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT
Deep vein thrombosis (DVT) is a major cause of morbidity and mortality in critically ill patients. DVT clots typically form in the sinus of the deep venous valves and are strongly associated with immobility and reduced venous flow. Physical activity alters venous blood flow, generating frequent periods of recirculatory flow and oscillatory shear stress (OSS) at venous valves. Endothelial sensing of OSS stimulates expression of a potent antithrombotic endothelial phenotype within the valve sinus, but the phenotype may be lost during prolonged immobility. To test whether restoring OSS-signaling in immobile subjects could prevent thrombosis, we applied rapid cycling compression devices (RCDs) unilaterally to brain-dead organ donors (BDOD), a clinically relevant translational model of critical illness. In healthy subjects, vascular ultrasound showed that RCDs recapitulate valve sinus recirculatory flow comparable to muscular activity. Additionally, in BDOD subjects, we found that RCD treatment caused significantly more valve sinus recirculatory flow compared to currently used sequential compression devices (SCDs). In BDOD, prolonged RCD therapy increased expression of OSS-regulated genes (FoxC2, Prox1) and suppressed adhesion molecules (P-selectin, CCL2). Further, RCD treatment reduced DVT and microthrombus formation in BDOD subjects compared to standard anticoagulation alone. Randomized comparisons with SCDs revealed no systemic biomarker differences, indicating that RCD effects were localized to valve endothelium. These results extend our previous findings by identifying endothelial shear-dependent signaling in response to OSS as a critical mediator of DVT molecular pathology and establishing targeted hemodynamic modulation as a potential strategy in a novel model of human critical illness.
- 18 August 2026
- Published by American Society of Hematology in Blood
Open AccessRestoration of oscillatory shear stress in humans activates an endothelial protective genetic program and prevents DVT
Deep vein thrombosis (DVT) is a major cause of morbidity and mortality in critically ill patients. DVT clots typically form in the sinus of the deep venous valves and are strongly associated with immobility and reduced venous flow. Physical activity alters venous blood flow, generating frequent periods of recirculatory flow and oscillatory shear stress (OSS) at venous valves. Endothelial sensing of OSS stimulates expression of a potent antithrombotic endothelial phenotype within the valve sinus, but the phenotype may be lost during prolonged immobility. To test whether restoring OSS-signaling in immobile subjects could prevent thrombosis, we applied rapid cycling compression devices (RCDs) unilaterally to brain-dead organ donors (BDOD), a clinically relevant translational model of critical illness. In healthy subjects, vascular ultrasound showed that RCDs recapitulate valve sinus recirculatory flow comparable to muscular activity. Additionally, in BDOD subjects, we found that RCD treatment caused significantly more valve sinus recirculatory flow compared to currently used sequential compression devices (SCDs). In BDOD, prolonged RCD therapy increased expression of OSS-regulated genes (FoxC2, Prox1) and suppressed adhesion molecules (P-selectin, CCL2). Further, RCD treatment reduced DVT and microthrombus formation in BDOD subjects compared to standard anticoagulation alone. Randomized comparisons with SCDs revealed no systemic biomarker differences, indicating that RCD effects were localized to valve endothelium. These results extend our previous findings by identifying endothelial shear-dependent signaling in response to OSS as a critical mediator of DVT molecular pathology and establishing targeted hemodynamic modulation as a potential strategy in a novel model of human critical illness.
- Open Access
- 26 February 2024
- Published by Springer Nature in Research Square
Distinct roles for LTalpha3 and LTalpha1beta2 produced by B cells contribute to their multi-faceted impact on ileitis
B lymphocytes may facilitate chronic inflammation through antibody production or secretion of cytokines, including lymphotoxin (LT)-a1b2 associated with development of lymphoid tissue. Tertiary lymphoid structures (TLS) characterize human and murine ileitis by suppressing outflow from the ileum. Here, we show that B cell-derived secretory IgA protected against ileal inflammation, whereas B cell-derived LTa guarded against ileitis-associated loss of body mass. We initially hypothesized this protection resulted from formation of TLS that suppressed lymphatic outflow and thereby restrained systemic spread of inflammatory signals, but B cell-selective deletion of LTb did not exacerbate weight loss, despite eliminating TLS. Instead, weight loss driven by the cachectic cytokine TNF was exacerbated when LTa3, another ligand for TNF receptors, was selectively neutralized. Thus, B cells’ multi-faceted impact on ileitis includes generating secretory IgA, expressing LTa1b2 to drive formation of TLS, and producing LTa3 for protecting against weight loss in the presence of TNF.
- 26 February 2024
- Published by Springer Nature in Research Square
Open AccessDistinct roles for LTalpha3 and LTalpha1beta2 produced by B cells contribute to their multi-faceted impact on ileitis
B lymphocytes may facilitate chronic inflammation through antibody production or secretion of cytokines, including lymphotoxin (LT)-a1b2 associated with development of lymphoid tissue. Tertiary lymphoid structures (TLS) characterize human and murine ileitis by suppressing outflow from the ileum. Here, we show that B cell-derived secretory IgA protected against ileal inflammation, whereas B cell-derived LTa guarded against ileitis-associated loss of body mass. We initially hypothesized this protection resulted from formation of TLS that suppressed lymphatic outflow and thereby restrained systemic spread of inflammatory signals, but B cell-selective deletion of LTb did not exacerbate weight loss, despite eliminating TLS. Instead, weight loss driven by the cachectic cytokine TNF was exacerbated when LTa3, another ligand for TNF receptors, was selectively neutralized. Thus, B cells’ multi-faceted impact on ileitis includes generating secretory IgA, expressing LTa1b2 to drive formation of TLS, and producing LTa3 for protecting against weight loss in the presence of TNF.
- Open Access
- 14 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0264979
Dysregulation of the leukocyte signaling landscape during acute COVID-19
The global COVID-19 pandemic has claimed the lives of more than 750,000 US citizens. Dysregulation of the immune system underlies the pathogenesis of COVID-19, with inflammation mediated tissue injury to the lung in the setting of suppressed systemic immune function. To define the molecular mechanisms of immune dysfunction in COVID-19 we utilized a systems immunology approach centered on the circulating leukocyte phosphoproteome measured by mass cytometry. We find that although COVID-19 is associated with wholesale activation of a broad set of signaling pathways across myeloid and lymphoid cell populations, STAT3 phosphorylation predominated in both monocytes and T cells. STAT3 phosphorylation was tightly correlated with circulating IL-6 levels and high levels of phospho-STAT3 was associated with decreased markers of myeloid cell maturation/activation and decreased ex-vivo T cell IFN-γ production, demonstrating that during COVID-19 dysregulated cellular activation is associated with suppression of immune effector cell function. Collectively, these data reconcile the systemic inflammatory response and functional immunosuppression induced by COVID-19 and suggest STAT3 signaling may be the central pathophysiologic mechanism driving immune dysfunction in COVID-19.
- 14 April 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0264979
Open AccessDysregulation of the leukocyte signaling landscape during acute COVID-19
The global COVID-19 pandemic has claimed the lives of more than 750,000 US citizens. Dysregulation of the immune system underlies the pathogenesis of COVID-19, with inflammation mediated tissue injury to the lung in the setting of suppressed systemic immune function. To define the molecular mechanisms of immune dysfunction in COVID-19 we utilized a systems immunology approach centered on the circulating leukocyte phosphoproteome measured by mass cytometry. We find that although COVID-19 is associated with wholesale activation of a broad set of signaling pathways across myeloid and lymphoid cell populations, STAT3 phosphorylation predominated in both monocytes and T cells. STAT3 phosphorylation was tightly correlated with circulating IL-6 levels and high levels of phospho-STAT3 was associated with decreased markers of myeloid cell maturation/activation and decreased ex-vivo T cell IFN-γ production, demonstrating that during COVID-19 dysregulated cellular activation is associated with suppression of immune effector cell function. Collectively, these data reconcile the systemic inflammatory response and functional immunosuppression induced by COVID-19 and suggest STAT3 signaling may be the central pathophysiologic mechanism driving immune dysfunction in COVID-19.
- Open Access
- 16 February 2021
- Published by Springer Nature in Research Square
Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19
The global COVID-19 pandemic has claimed the lives of more than 450,000 US citizens. Dysregulation of the immune system underlies the pathogenesis of COVID-19, with inflammation mediated local tissue injury to the lung in the setting of suppressed systemic immune function. To define the molecular mechanisms of immune dysfunction in COVID-19 we utilized a systems immunology approach centered on the circulating leukocyte phosphoproteome measured by mass cytometry. COVID-19 is associated with wholesale activation of a broad set of signaling pathways across myeloid and lymphoid cell populations. STAT3 phosphorylation predominated in both monocytes and T cells and was tightly correlated with circulating IL-6 levels. High levels of STAT3 phosphorylation was associated with decreased markers of myeloid cell maturation/activation and decreased ex-vivo T cell IFN-gamma production, demonstrating that during COVID-19 dysregulated cellular activation is associated with suppression of immune effector cell function. Collectively, these data reconcile the systemic inflammatory response and functional immunosuppression induced by COVID-19 and suggest STAT3 signaling may be the central pathophysiologic mechanism driving immune dysfunction in COVID-19.
- 16 February 2021
- Published by Springer Nature in Research Square
Open AccessDysregulation of the Leukocyte Signaling Landscape during Acute COVID-19
The global COVID-19 pandemic has claimed the lives of more than 450,000 US citizens. Dysregulation of the immune system underlies the pathogenesis of COVID-19, with inflammation mediated local tissue injury to the lung in the setting of suppressed systemic immune function. To define the molecular mechanisms of immune dysfunction in COVID-19 we utilized a systems immunology approach centered on the circulating leukocyte phosphoproteome measured by mass cytometry. COVID-19 is associated with wholesale activation of a broad set of signaling pathways across myeloid and lymphoid cell populations. STAT3 phosphorylation predominated in both monocytes and T cells and was tightly correlated with circulating IL-6 levels. High levels of STAT3 phosphorylation was associated with decreased markers of myeloid cell maturation/activation and decreased ex-vivo T cell IFN-gamma production, demonstrating that during COVID-19 dysregulated cellular activation is associated with suppression of immune effector cell function. Collectively, these data reconcile the systemic inflammatory response and functional immunosuppression induced by COVID-19 and suggest STAT3 signaling may be the central pathophysiologic mechanism driving immune dysfunction in COVID-19.
- 1 May 2019
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 86 (5) , 797-802
American firearm homicides: The impact of your neighbors
BACKGROUND: Restrictive firearm legislation has correlated with decreased overall firearm fatality rates, but not with firearm-related homicide or firearm mortality among Black Americans. We hypothesized that firearm trafficking from states with less restrictive firearm legislation to neighboring states with more restrictive firearm legislation increases firearm homicide rates in those restrictive states. METHODS: For years 2011–2015, state firearm legislation Brady Campaign to Prevent Gun Violence scorecards were analyzed in relation to firearms traced by the Bureau of Alcohol, Tobacco, and Firearms and Center for Disease Control and Prevention firearm mortality rates. States were ranked by Brady score and arranged by quintile to establish the Standardized Brady Score. The effect of less-restrictive neighboring states on the 10 most-restrictive firearm legislation states was modeled by averaging the 10 most-restrictive states with their bordering states to create a Border Adjustment Score. Firearm fatality rates were calculated for each quintile and Poisson regression models were created for each score and outcome. Model fit was compared using Akaike Information Criterion (AIC). RESULTS: There were 169,396 firearm fatalities including 57,885 firearm homicides. Comparing top and bottom quintile firearm legislation states, 65% vs. 44% of firearms traced by the Bureau of Alcohol, Tobacco, Firearms and Explosives originated in other states respectively. The Border Adjustment Score generated a more linear relationship than the Standardized Brady Score for all firearm fatality categories as firearm legislation scores decreased. The Border Adjustment Score minimized the AIC with respect to the Standardized Brady Score for black (AIC, 4443 vs. 4680) and white firearm homicide rates (3243 vs. 4319), indicating improved model fit after adjustment for neighboring state firearm legislation. CONCLUSION: Our results suggest that firearm movement across states plays an important role in firearm homicides. Accounting for firearm legislation in both individual and neighboring states may improve our understanding of the relationship between firearm legislation and homicide. LEVEL OF EVIDENCE: Prognostic and epidemiological study, level IV.
- 1 May 2019
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 86 (5) , 797-802
American firearm homicides: The impact of your neighbors
BACKGROUND: Restrictive firearm legislation has correlated with decreased overall firearm fatality rates, but not with firearm-related homicide or firearm mortality among Black Americans. We hypothesized that firearm trafficking from states with less restrictive firearm legislation to neighboring states with more restrictive firearm legislation increases firearm homicide rates in those restrictive states. METHODS: For years 2011–2015, state firearm legislation Brady Campaign to Prevent Gun Violence scorecards were analyzed in relation to firearms traced by the Bureau of Alcohol, Tobacco, and Firearms and Center for Disease Control and Prevention firearm mortality rates. States were ranked by Brady score and arranged by quintile to establish the Standardized Brady Score. The effect of less-restrictive neighboring states on the 10 most-restrictive firearm legislation states was modeled by averaging the 10 most-restrictive states with their bordering states to create a Border Adjustment Score. Firearm fatality rates were calculated for each quintile and Poisson regression models were created for each score and outcome. Model fit was compared using Akaike Information Criterion (AIC). RESULTS: There were 169,396 firearm fatalities including 57,885 firearm homicides. Comparing top and bottom quintile firearm legislation states, 65% vs. 44% of firearms traced by the Bureau of Alcohol, Tobacco, Firearms and Explosives originated in other states respectively. The Border Adjustment Score generated a more linear relationship than the Standardized Brady Score for all firearm fatality categories as firearm legislation scores decreased. The Border Adjustment Score minimized the AIC with respect to the Standardized Brady Score for black (AIC, 4443 vs. 4680) and white firearm homicide rates (3243 vs. 4319), indicating improved model fit after adjustment for neighboring state firearm legislation. CONCLUSION: Our results suggest that firearm movement across states plays an important role in firearm homicides. Accounting for firearm legislation in both individual and neighboring states may improve our understanding of the relationship between firearm legislation and homicide. LEVEL OF EVIDENCE: Prognostic and epidemiological study, level IV.
- 1 December 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 68 (6) , 222S-233S.e1
Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis
- 1 December 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 68 (6) , 222S-233S.e1
Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis
- Open Access
- 15 June 2017
- Published by American Society of Hematology in Blood
- Vol. 129 (24) , 3245-3255
Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice
Key Points: Endogenous p53 within myeloid cells regulates venous thrombus resolution, intrathrombus macrophage polarization, and fibrosis. The p53 agonist quinacrine accelerates resolution of established venous thrombus, a potential translational benefit in patients with DVT.
- 15 June 2017
- Published by American Society of Hematology in Blood
- Vol. 129 (24) , 3245-3255
Open AccessMyeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice
Key Points: Endogenous p53 within myeloid cells regulates venous thrombus resolution, intrathrombus macrophage polarization, and fibrosis. The p53 agonist quinacrine accelerates resolution of established venous thrombus, a potential translational benefit in patients with DVT.
- 1 January 2015
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 3 (1) , 64-74
Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo
- 1 January 2015
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 3 (1) , 64-74
Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo
- Open Access
- 10 July 2014
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 12 (10) , 1706-1716
Enhanced venous thrombus resolution in plasminogen activator inhibitor type‐2 deficient mice
- 10 July 2014
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 12 (10) , 1706-1716
Open AccessEnhanced venous thrombus resolution in plasminogen activator inhibitor type‐2 deficient mice
- 1 May 2012
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (suppl_1)
Abstract 9: Two Distinct Roles of Plasminogen Activator Inhibitor-2 (PAI) and PAI-1 in Deep Vein Thrombosis
Objectives: Urokinase-plasminogen activator (uPA) has a vital role in deep vein thrombosis (DVT). While PAI-1 is the main inhibitor of uPA in vivo, PAI-2, found mostly intracellularly, has proven to have more anti-inflammatory and anti-apoptotic than anti-fibrinolytic activities. We explored the hypothesis that PAI-1 and PAI-2 play roles in DVT through either fibrinolytic or inflammatory pathways. Methods: Wild type C57Bl/6 (WT), PAI-2 -/-, and PAI-1 -/- mice underwent surgical caval ligation. Subsequent thrombus was harvested at various time points and measured for thrombus weight (TW) normalized to body weight. Tissue was analyzed by western blot, ELISAs, zymography and flow cytometry. Results: PAI-2 deficiency resulted in unchanged thrombus formation (TW day 4: WT = 1.037 ± .043 mg/g n=17; PAI-2 -/- = 1.028 ± .067 mg/g n=17, p=.91), while it enhanced thrombus resolution (TW day 12: WT = .43 ± .03 mg/g n=13; PAI-2 -/- = .319 ± .021 mg/g, n=16, p=.004). PAI-1 deficiency caused decreased formation (TW day 12: PAI-1 -/- = .901 ± .043 mg/g n=11, p=.045) and enhanced resolution (TW day 12: PAI-1 -/- = .248 ± .011 mg/g n=10, p=.00004). Though total uPA levels in thrombi were similar between groups, active uPA by ELISA was increased by 5 fold in PAI-1 -/- mice and 40 fold in PAI-2 -/- mice compared to WT mice at day 12, indicating increased uPA-mediated fibrinolysis. Exploring other mediators of resolution, we found that PAI-1 and PAI-2 deficiencies lead to contrasting results. By zymography, PAI-1 deficiency caused an early increase in matrix metalloproteinase (MMP) activity that decreased over time. Conversely, PAI-2 deficiency trended towards less early MMP activity that then increased. Using flow cytometry to assess clot cell populations, on day 4, PAI-2-/- mice had an increase in neutrophils with a decrease in macrophages, whereas PAI-1-/- mice had an increase in macrophages. Conclusions: This identifies PAI-2 as a novel regulator of venous thrombus resolution and suggests the first context in vivo in which PAI-2 has an anti-fibrinolytic role. Both PAI-1 and PAI-2 deficiencies enhance thrombus resolution, but through diverging mechanisms. Further examination of these pathways may lead to potential therapeutic prospects in accelerating thrombus resolution.
- 1 May 2012
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (suppl_1)
Abstract 9: Two Distinct Roles of Plasminogen Activator Inhibitor-2 (PAI) and PAI-1 in Deep Vein Thrombosis
Objectives: Urokinase-plasminogen activator (uPA) has a vital role in deep vein thrombosis (DVT). While PAI-1 is the main inhibitor of uPA in vivo, PAI-2, found mostly intracellularly, has proven to have more anti-inflammatory and anti-apoptotic than anti-fibrinolytic activities. We explored the hypothesis that PAI-1 and PAI-2 play roles in DVT through either fibrinolytic or inflammatory pathways. Methods: Wild type C57Bl/6 (WT), PAI-2 -/-, and PAI-1 -/- mice underwent surgical caval ligation. Subsequent thrombus was harvested at various time points and measured for thrombus weight (TW) normalized to body weight. Tissue was analyzed by western blot, ELISAs, zymography and flow cytometry. Results: PAI-2 deficiency resulted in unchanged thrombus formation (TW day 4: WT = 1.037 ± .043 mg/g n=17; PAI-2 -/- = 1.028 ± .067 mg/g n=17, p=.91), while it enhanced thrombus resolution (TW day 12: WT = .43 ± .03 mg/g n=13; PAI-2 -/- = .319 ± .021 mg/g, n=16, p=.004). PAI-1 deficiency caused decreased formation (TW day 12: PAI-1 -/- = .901 ± .043 mg/g n=11, p=.045) and enhanced resolution (TW day 12: PAI-1 -/- = .248 ± .011 mg/g n=10, p=.00004). Though total uPA levels in thrombi were similar between groups, active uPA by ELISA was increased by 5 fold in PAI-1 -/- mice and 40 fold in PAI-2 -/- mice compared to WT mice at day 12, indicating increased uPA-mediated fibrinolysis. Exploring other mediators of resolution, we found that PAI-1 and PAI-2 deficiencies lead to contrasting results. By zymography, PAI-1 deficiency caused an early increase in matrix metalloproteinase (MMP) activity that decreased over time. Conversely, PAI-2 deficiency trended towards less early MMP activity that then increased. Using flow cytometry to assess clot cell populations, on day 4, PAI-2-/- mice had an increase in neutrophils with a decrease in macrophages, whereas PAI-1-/- mice had an increase in macrophages. Conclusions: This identifies PAI-2 as a novel regulator of venous thrombus resolution and suggests the first context in vivo in which PAI-2 has an anti-fibrinolytic role. Both PAI-1 and PAI-2 deficiencies enhance thrombus resolution, but through diverging mechanisms. Further examination of these pathways may lead to potential therapeutic prospects in accelerating thrombus resolution.